Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CRCA vs. CRY: which is better?

Bottom line

CRCA vs CRY: the short answer

CRCA (ProShares Ultra CRCL) and CRY (GraniteShares YieldBOOST CRCL ETF) are both etfs.

Updated Nov 19, 2026

CRCA vs CRY side by side

CRCACRY
TypeETFETF
Fund familyProSharesGraniteshares Yieldboost Crcl
CategoryOtherOther
Expense ratio0.95%—
Annual cost per $10k$95—
10-yr cost on $10k (prospectus)$1,231—
Max front loadNoneNone
12b-1 fee——
1-yr return——
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter——
Worst quarter——
Net assets (fund)$227.5M—
Number of holdings11—
Portfolio turnover%—
Returns as of——

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CRCA and CRY share none of their top holdings.

CRCA top 10

  1. Repurchase Agreement — 6.18%
  2. N/a — 4.32%
  3. Repurchase Agreement — 3.89%
  4. Repurchase Agreement — 2.92%
  5. Repurchase Agreement — 2.14%
  6. N/a — 0.21%
  7. N/a — -2.27%
  8. N/a — -2.52%
  9. N/a — -2.98%
  10. N/a — -3.09%

CRY top 10

    FAQ

    What is the difference between CRCA and CRY?
    CRCA (ProShares Ultra CRCL) and CRY (GraniteShares YieldBOOST CRCL ETF) are both etfs.
    Should I own both CRCA and CRY?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.